EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

One-Week Kava Dietary Supplementation Increases Both Urinary N - and O -Glucuronides of NNAL, a Lung Carcinogen Major Metabolite, among Smokers

Qi Hu, Zhixin Tang, Allison Lynch, Breanne Freeman, Naomi Fujioka, Ramzi G Salloum, John Malaty, Frank A Orlando, Taimour Langaee, Zhiguang Huo, Chengguo Xing iD

Chemical Research in Toxicology · 2024

DOI: 10.1021/acs.chemrestox.4c00109 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Chemical Research in Toxicology, 2024. Verfasst von Qi Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development (CNPD3), College of Pharmacy, University of Florida, G…. Hauptthemen laut MEDLINE: Kava, Nitrosamines, Carcinogens, Glucuronides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: NCI NIH HHS, NCCIH NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (commonly known as NNK) is one of the most prevalent and potent pulmonary carcinogens in tobacco products that increases the human lung cancer risk. Kava has the potential to reduce NNK and tobacco smoke-induced lung cancer risk by enhancing urinary excretion of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL, the major metabolite of NNK) and thus reducing NNK-induced DNA damage. In this study, we quantified N-glucuronidated NNAL (NNAL-N-gluc), O-glucuronidated NNAL (NNAL-O-gluc), and free NNAL in the urine samples collected before and after 1-week kava dietary supplementation. The results showed that kava increased both NNAL-N-glucuronidation and O-glucuronidation. Since NNAL-N-glucuronidation is dominantly catalyzed by UGT2B10, its representative single-nucleotide polymorphisms (SNPs) were analyzed among the clinical trial participants. Individuals with any of the four analyzed SNPs appear to have a reduced basal capacity in NNAL-N-glucuronidation. Among these individuals, kava also resulted in a smaller extent of increases in NNAL-N-glucuronidation, suggesting that participants with those UGT2B10 SNPs may not benefit as much from kava with respect to enhancing NNAL-N-glucuronidation. In summary, our results provide further evidence that kava enhances NNAL urinary detoxification via an increase in both N-glucuronidation and O-glucuronidation. UGT2B10 genetic status has not only the potential to predict the basal capacity of the participants in NNAL-N-glucuronidation but also potentially the extent of kava benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KavaNitrosaminesCarcinogensGlucuronidesDietary SupplementsHumansMaleFemaleLung NeoplasmsMiddle AgedPyridinesSmokingSmokersGlucuronosyltransferaseAdultPolymorphism, Single Nucleotide

Substanzen

NitrosaminesCarcinogensGlucuronides4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanonePyridinesGlucuronosyltransferase

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, Center for Natural Products, Drug Discovery and Development (CNPD3), College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.
  • Department of Biostatistics, Colleges of Public Health & Health Professions and Medicine, University of Florida, Gainesville, Florida 32610, United States.
  • Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455, United States.
  • Department of Health Outcomes & Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida 32610, United States.
  • Department of Community Health & Family Medicine, College of Medicine, University of Florida, Gainesville, Florida 32610, United States.
  • Center for Pharmacogenomics and Precision Medicine, Department of Pharmacotherapy & Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.

ORCID-Profile: Chengguo Xing

Förderung

  • NCI NIH HHS
  • NCCIH NIH HHS
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences
  • Division of Cancer Prevention, National Cancer Institute
  • Florida Department of Health
  • National Center for Complementary and Integrative Health

Zitieren

APA

Hu, Q., Tang, Z., Lynch, A., Freeman, B., Fujioka, N., Salloum, R. G., Malaty, J., Orlando, F. A., Langaee, T., Huo, Z., & Xing, C. (2024). One-Week Kava Dietary Supplementation Increases Both Urinary N - and O -Glucuronides of NNAL, a Lung Carcinogen Major Metabolite, among Smokers. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.4c00109

Vancouver

Hu Q, Tang Z, Lynch A, Freeman B, Fujioka N, Salloum RG, et al. One-Week Kava Dietary Supplementation Increases Both Urinary N - and O -Glucuronides of NNAL, a Lung Carcinogen Major Metabolite, among Smokers. Chemical Research in Toxicology. 2024. doi:10.1021/acs.chemrestox.4c00109

BibTeX
@article{Hu2024,
  author = {Hu, Qi and Tang, Zhixin and Lynch, Allison and Freeman, Breanne and Fujioka, Naomi and Salloum, Ramzi G and Malaty, John and Orlando, Frank A and Langaee, Taimour and Huo, Zhiguang and Xing, Chengguo},
  title = {One-Week Kava Dietary Supplementation Increases Both Urinary N - and O -Glucuronides of NNAL, a Lung Carcinogen Major Metabolite, among Smokers},
  journal = {Chemical Research in Toxicology},
  year = {2024},
  doi = {10.1021/acs.chemrestox.4c00109}
}
Kostenlos starten →